Why the study?
Variants in ion channel genes have classically been studied in low throughput by patch clamping, whereas deep mutational scanning can simultaneously assess the function of thousands of variants.
Deep mutational scanning provides an accurate, high-throughput in vitro method to identify deleterious variants in the SCN5A cardiac sodium channel gene.
Answers are grounded in this paper and cite their sources.
Enables high-throughput SCN5A variant assessment; leaves open clinical translation pending further validation.
Background: Variants in ion channel genes have classically been studied in low throughput by patch clamping. Deep mutational scanning is a complementary approach that can simultaneously assess function of thousands of variants. Methods: We have developed and validated a method to perform a deep mutational scan of variants in SCN5A , which encodes the major voltage-gated sodium channel in the heart. We created a library of nearly all possible variants in a 36 base region of SCN5A in the S4 voltage sensor of domain IV and stably integrated the library into HEK293T cells. Results: In preliminary experiments, challenge with 3 drugs (veratridine, brevetoxin, and ouabain) could discriminate wild-type channels from gain- and loss-of-function pathogenic variants. High-throughput sequencing of the pre- and postdrug challenge pools was used to count the prevalence of each variant and identify variants with abnormal function. The deep mutational scan scores identified 40 putative gain-of-function and 33 putative loss-of-function variants. For 8 of 9 variants, patch clamping data were consistent with the scores. Conclusions: These experiments demonstrate the accuracy of a high-throughput in vitro scan of SCN5A variant function, which can be used to identify deleterious variants in SCN5A and other ion channel genes.
No takes yet. Share an insight, caveat, or question.
Glazer et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: